Aurobindo To Buyout Actavis' EU Ops
  • Prabha Hedge
  • Jan 20 2014

January 20: Aurobindo Pharma has inked a deal to buy Actavis' generic operations in seven Western European countries. Aurobindo will pay $41 million for the Dublin-based drug maker's generic products, marketing authorizations and license rights in countries including France and Italy. Bloomberg TV India’s Agam Vakil shares a detailed report.